|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：W499305 |
| 產(chǎn)品名稱：WNK 463 |
| 產(chǎn)品CAS：2012607-27-9 |
| 規(guī)格含量：2.5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
W499305 |
| 名稱: |
WNK 463 |
| 別名: |
N-(1,1-Dimethylethyl)-1-[1-[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]-4-piperidinyl]-1H-imidazole-5-carboxamide |
| CAS號(hào): |
2012607-27-9 |
| 分子式: |
C??H??F?N?O? |
| 分子量: |
463.46 |
| 類別: |
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
WNK 463, is a pan-WNK kinase inhibitor, acting on WNK1, WNK2, WNK3, and WNK4 kinases. It has shown to affect blood pressure, heart rate, body fluid and electrolyte homeostasis in rodent models of hypertension. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
